|
AP1AR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00530000049604E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2757000000807E-07 |
| Normal-vs-Stage2 |
1.523870E-02 |
| Normal-vs-Stage3 |
7.649800E-04 |
| Normal-vs-Stage4 |
8.208700E-04 |
| Stage1-vs-Stage2 |
1.940590E-01 |
| Stage1-vs-Stage3 |
6.124000E-01 |
| Stage1-vs-Stage4 |
9.290600E-01 |
| Stage2-vs-Stage3 |
4.480000E-01 |
| Stage2-vs-Stage4 |
3.576000E-01 |
| Stage3-vs-Stage4 |
8.037600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04680000001522E-07 |
| Normal-vs-AfricanAmerican |
1.752260E-04 |
| Normal-vs-Asian |
1.739000E-01 |
| Caucasian-vs-AfricanAmerican |
4.268600E-01 |
| Caucasian-vs-Asian |
9.606800E-01 |
| AfricanAmerican-vs-Asian |
8.361400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12149999953459E-07 |
| Normal-vs-Female |
9.5001000000039E-05 |
| Male-vs-Female |
3.384000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.34480000000015E-05 |
| Normal-vs-Extreme_Weight |
5.74999999836123E-08 |
| Normal-vs-Obese |
1.025570E-04 |
| Normal-vs-Extreme_Obese |
1.395670E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.901200E-01 |
| Normal_Weight-vs-Obese |
6.037400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.442200E-01 |
| Extreme_Weight-vs-Obese |
2.141200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.300600E-01 |
| Obese-vs-Extreme_Obese |
7.152000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.424120E-04 |
| Normal-vs-Age(41-60Yrs) |
3.6817999999883E-06 |
| Normal-vs-Age(61-80Yrs) |
1.21919999984677E-07 |
| Normal-vs-Age(81-100Yrs) |
1.777170E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.594200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.182200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.484400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.649000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.608000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.500800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.38890000003877E-07 |
| Normal-VS-Type2 PRCC |
1.407380E-04 |
| Normal-VS-KIRP CIMP |
5.978700E-04 |
| Normal-VS-Unclassified PRCC |
1.73758999999496E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.798800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.989200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.723400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.398800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.246800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.098600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.85439999997617E-06 |
| Normal-vs-N1 |
3.73449999999664E-05 |
| Normal-vs-N2 |
6.156900E-04 |
| N0-vs-N1 |
8.670200E-01 |
| N0-vs-N2 |
3.728600E-01 |
| N1-vs-N2 |
3.465600E-01 |
|
|
